A carregar...

Neoadjuvant Therapy in Operable Breast Cancer: Application to Triple Negative Breast Cancer

Systemic treatment for triple negative breast cancer (TNBC: negative for the expression of estrogen receptor and progesterone receptor and HER2 amplification) has been limited to chemotherapy options. Neoadjuvant chemotherapy induces tumor shrinkage and improves the surgical outcomes of patients wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ademuyiwa, Foluso O., Ellis, Matthew J., Ma, Cynthia X.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3747378/
https://ncbi.nlm.nih.gov/pubmed/23983689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/219869
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!